SCD40L AND PLACENTAL GROWTH FACTOR (PLGF) USED AS A BIOCHEMICAL MARKER COMBINATION IN CARDIOVASCULAR DISEASES

摘要

The invention relates to novel markers of vascular inflammation and to combinations thereof that are used as diagnosis and prognosis tools in patients suffering from cardiovascular diseases. The markers also act as tools to facilitate the selection of active ingredients for treating diseases of this type and constitute the starting point for the treatment of cardiovascular diseases. The invention also relates to the creation of an individual risk profile of negative events, which are associated with the progression of arteriosclerosis.